Global Collagen & Gelatin (Bovine, Porcine, Marine) Markets, 2021-2026: Focus on Wound Care, Orthopedic, Cardiovascular Disease, Dental, Surgical, Dural - ResearchAndMarkets.com

·3 min read

DUBLIN, July 27, 2021--(BUSINESS WIRE)--The "Global Collagen & Gelatin Market by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular Disease, Dental, Surgical, Dural), End-user (Hospitals, Surgical Centers), and Region - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

The global collagen and gelatin market is projected to reach USD 1,083 million by 2026 from USD 772 million in 2021, at a CAGR of 7% during the forecast period.

Diabetes is an important target indication - it can increase the incidence and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and surgical wounds, requiring treatments and incurring exorbitant medical expenses. Nearly 25% of diabetics in the US develop foot ulcers during their lifetime, while ~15% of the diabetic population suffers from diabetic foot ulcers (DFUs).

The increasing prevalence of DFUs is expected to drive the demand for regenerative medicine products like grafts and matrices. Thus, fueling the market growth. However, the availability of alternative biomaterials is likely to hinder the market growth.

The porcine segment accounted for the highest growth rate in the collagen and gelatin market, by source, during the forecast period

Based on source, the global collagen and gelatin market is segmented into bovine, porcine, and other sources. The porcine segment is projected to grow at the highest CAGR during the forecast period. This is mainly due to its high biocompatibility and bioactivity that account for its use as a scaffolding material in tissue engineering.

Orthopedic application segment accounted for the largest share

Based on application, the global collagen market is segmented into orthopedic, wound care, dental, surgical, cardiovascular, and other applications. The global gelatin market is segmented into orthopedic, wound care, and others. The orthopedic segment accounted for the largest share of 37.5% of the collagen market and 41.5% of the gelatin market in 2020, mainly due to the increasing use of these biomaterials in orthopedic surgeries and the high demand for scaffolds for bone substitutes.

Asia Pacific: The fastest-growing region in the collagen and gelatin market

The collagen and gelatin market is segmented into North America, Europe, Asia Pacific, and RoW. The collagen and gelatin market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in the APAC market is driven by rising geriatric population in Japan and China, increasing prevalence of chronic wounds, and growth in the number of people suffering from pressure ulcers.

Market Dynamics

Drivers

  • Growing Incidence of Diabetes, Cancer, and Chronic Wounds

  • Rising Funding and Investments for R&D

  • Growing Number of Surgical Procedures

Restraints

  • Availability of Alternative Biomaterials

Opportunities

  • Implementation of the 21st Century Cures Act

  • Ranges/Scenarios

Impact of the COVID-19 Pandemic on the Collagen and Gelatin Market

YC-YCC Shift

Value Chain Analysis

Supply Chain

Ecosystem Analysis

Technology Analysis

Regulatory Analysis

Patent Analysis

Company Profiles

Key Companies

  • Integra Lifesciences

  • Royal DSM

  • Collplant Biotechnologies Ltd.

  • Nitta Gelatin Inc.

  • Collagen Solutions PLC

  • Collagen Matrix, Inc.

  • Symatese

  • Gelita AG

  • PB Leiner

  • Smith & Nephew PLC

  • Zimmer Biomet

  • Jellagen

Other Players

  • Advanced Biomatrix

  • Matricel GmbH

  • Rousselot

  • Weishardt

  • Xiamen Hyfine Gelatin

  • Geistlich Pharma AG

  • Synerheal Pharmaceuticals

  • Bioregen Technologies

  • Meril Life Sciences Pvt. Ltd.

  • Medskin Solutions Dr. Suwelack

  • Cologenesis Healthcare Pvt. Ltd.

  • DermaRite Industries, LLC

  • Eucare Pharmaceuticals Private Limited

For more information about this report visit https://www.researchandmarkets.com/r/hr7vt7

View source version on businesswire.com: https://www.businesswire.com/news/home/20210727005587/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting